Teo AKJ, Singh SR, Prem K, Hsu LY, Yi S. Duration and determinants of delayed tuberculosis diagnosis and treatment in high-burden countries: a mixed-methods systematic review and meta-analysis. Respir Res. 2021;22(1)
Organization WH. Global tuberculosis report. 2023
Elbrolosy AM, El Helbawy RH, Mansour OM, Latif RA. Diagnostic utility of GeneXpert MTB/RIF assay versus conventional methods for diagnosis of pulmonary and extra-pulmonary tuberculosis. BMC Microbiol. 2021;21(1)
Nolt D, Starke JR. Tuberculosis infection in children and adolescents: testing and treatment. Pediatrics. 2021;148(6)
Engel N, Ochodo EA, Karanja PW, Schmidt B-M, Janssen R, Steingart KR, Oliver S. Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views. Cochrane Database Syst Rev. 2022;2022(4)
Chang A, Loy CJ, Eweis-LaBolle D, Lenz JS, Steadman A, Andgrama A, Nhung NV, Yu C, Worodria W, Denkinger CM, et al. Circulating cell-free rna in blood as a host response biomarker for detection of tuberculosis. Nat Commun. 2024;15(1)
Qin ZZ, Ahmed S, Sarker MS, Paul K, Adel ASS, Naheyan T, Barrett R, Banu S, Creswell J. Tuberculosis detection from chest x-rays for triaging in a high tuberculosis-burden setting: an evaluation of five artificial intelligence algorithms. The Lancet Digit Health. 2021;3(9):e543–54
Hrizi O, Gasmi K, Ben Ltaifa I, Alshammari H, Karamti H, Krichen M, Ben Ammar L, Mahmood MA, Li X. Tuberculosis disease diagnosis based on an optimized machine learning Model. J Healthc Eng. 2022, 2022;1–13
Asnicar F, Thomas AM, Passerini A, Waldron L, Segata N. Machine learning for microbiologists. Nat Rev Microbiol. 2023;22(4):191–205
Salehnasab Z, Mousavizadeh A, Ghalamfarsa G, Garavand A, Salehnasab C. Predictive modeling of COVID-19 hospitalization using twenty machine learning classification algorithms on cohort data. Front Health Inf. 2023;12
Vasiliu A, Martinez L, Gupta RK, Hamada Y, Ness T, Kay A, Bonnet M, Sester M, Kaufmann SHE, Lange C, et al. Tuberculosis prevention: current strategies and future directions. Clin Microbiol And Infect. 2024;30(9):1123–30
Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):191–205
Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Mak. 2006;26(6):565–74
Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, Pencina MJ, Kattan MW. Assessing the performance of prediction models. Epidemiology. 2010;21(1):128–38
Park SY, Park JE, Kim H, Park SH. Review of statistical methods for evaluating the performance of survival or other time-to-event prediction models (from conventional to deep learning approaches). Korean J Radiol. 2021;22(10)
Lundberg SM, Erion G, Chen H, DeGrave A, Prutkin JM, Nair B, Katz R, Himmelfarb J, Bansal N, Lee S-I. From local explanations to global understanding with explainable ai for trees. Nat Mach Intell. 2020;2(1):56–67
J FEH. Regression modeling strategies with applications to linear models, logistic and ordinal regression, and survival analysis. Springer Ser Stat. 2015
Myung Y, Jeon S, Heo C, Kim E-K, Kang E, Shin H-C, Yang E-J, Jeong JH. Validating machine learning approaches for prediction of donor related complication in microsurgical breast reconstruction: a retrospective cohort study. Sci Rep. 2021;11(1)
Wang W, L-F W, Y-Y L, Yang F, Zhu L, X-H Z. Value of the ratio of monocytes to lymphocytes for monitoring tuberculosis therapy. Can J Infect Dis Med Microbiol. 2019, 2019;1–5
Chendi BH, Snyders CI, Tonby K, Jenum S, Kidd M, Walzl G, Chegou NN, Dyrhol-Riise AM. A plasma 5-marker Host biosignature identifies tuberculosis in high and Low endemic countries. Front Immunol. 2021;12
Mutavhatsindi H, van der Spuy GD, Malherbe ST, Sutherland JS, Geluk A, Mayanja-Kizza H, Crampin AC, Kassa D, Howe R, Mihret A, et al. Validation and optimization of Host immunological bio-signatures for a point-of-care test for tb disease. Front Immunol. 2021;12
Morris TC, Hoggart CJ, Chegou NN, Kidd M, Oni T, Goliath R, Wilkinson KA, Dockrell HM, Sichali L, Banda L, et al. Evaluation of Host serum protein Biomarkers of tuberculosis in sub-saharan Africa. Front Immunol. 2021;12
Luo Y, Tang G, Lin Q, Mao L, Xue Y, Yuan X, Ouyang R, Wu S, Yu J, Zhou Y, et al. Combination of mean spot sizes of ESAT-6 spot-forming cells and modified tuberculosis-specific antigen/phytohemagglutinin ratio of T-SPOT.TB assay in distinguishing between active tuberculosis and latent tuberculosis infection. The J Infect. 2020;81(1):81–89
Luo Y, Xue Y, Tang G, Lin Q, Song H, Liu W, Yin B, Huang J, Wei W, Mao L, et al. Combination of HLA-DR on Mycobacterium tuberculosis-specific cells and tuberculosis Antigen/Phytohemagglutinin ratio for discriminating active tuberculosis from latent tuberculosis infection. Frontiers in immunology. 2021;12
Togun T, Hoggart CJ, Agbla SC, Gomez MP, Egere U, Sillah AK, Saidy B, Mendy F, Pai M, Kampmann B. A three-marker protein biosignature distinguishes tuberculosis from other respiratory diseases in Gambian children. EBioMedicine. 2020;58
Turner CT, Gupta RK, Tsaliki E, Roe JK, Mondal P, Nyawo GR, Palmer Z, Miller RF, Reeve BWP, Theron G, et al. Blood transcriptional biomarkers for active pulmonary tuberculosis in a high-burden setting: a prospective, observational, diagnostic accuracy study. The Lancet Respir Med. 2020;8(4):407–19
Luo Y, Xue Y, Song H, Tang G, Liu W, Bai H, Yuan X, Tong S, Wang F, Cai Y, et al. Machine learning based on routine laboratory indicators promoting the discrimination between active tuberculosis and latent tuberculosis infection. The J Infect. 2022;84(5):648–57
Luo Y, Xue Y, Liu W, Song H, Huang Y, Tang G, Wang F, Wang Q, Cai Y, Sun Z. Development of diagnostic algorithm using machine learning for distinguishing between active tuberculosis and latent tuberculosis infection. BMC Infect Dis. 2022;22(1)
Xing Z, Ding W, Zhang S, Zhong L, Wang L, Wang J, Wang K, Xie Y, Zhao X, Li N, et al. Machine learning-based differentiation of nontuberculous mycobacteria lung disease and pulmonary tuberculosis using ct images. Biomed Res Int. 2020;2020(1)
Zhou Z, Zhou X, Cheng L, Wen L, An T, Gao H, Deng H, Yan Q, Zhang X, Li Y, et al. Machine learning algorithms utilizing blood parameters enable early detection of immunethrombotic dysregulation in COVID-19. Clin Transl Med. 2021;11(9)
Salehnasab C, Hajifathali A, Asadi F, Parkhideh S, Kazemi A, Roshanpoor A, Mehdizadeh M, Tavakoli-Ardakani M, Roshandel E. An intelligent clinical decision support system for predicting acute graft-versus-host disease (aGvhd) following allogeneic hematopoietic stem cell transplantation. J Biomed Phys Eng. 2021;11(3):345–56
Wang Z, Guo Z, Wang W, Zhang Q, Song S, Xue Y, Zhang Z, Wang J. Prediction of tuberculosis treatment outcomes using biochemical makers with machine learning. BMC Infect Dis. 2025;25(1)
Bartl L, Zeeb M, Kälin M, Loosli T, Notter J, Furrer H, Hoffmann M, Hirsch HH, Zangerle R, Grabmeier-Pfistershammer K, et al. Machine learning-based prediction of active tuberculosis in people with human immunodeficiency virus using clinical data. Clin Infect Dis. 2025
Lin M, Lu H-C, Lin H-W, Pan S-W, Cheng B-M, Tseng T-R, Feng J-Y, Ho M-L. Fast screening of tuberculosis patients based on analysis of plasma by infrared spectroscopy coupled with machine learning approaches. ACS Omega. 2025;10(12):11817–27
Stanciu I-V, Fildan A-P, Thakur BR, Ilie AC, Stanga L, Oancea C, Tudorache E, Bratosin F, Rosca O, Bogdan I, et al. Full-blood inflammatory ratios predict length of stay but not early death in Romanian pulmonary tuberculosis. Medicina. 2025;61(7)
Yu Q, Guo J, Gong F. Construction and validation of a diagnostic scoring system for predicting active pulmonary tuberculosis in patients with positive T-SPOT based on indicators associated with coagulation and inflammation: a retrospective cross-sectional study. Infect Drug Resist. 2023;16:5755–64
Yu Q, Luo H, Hu S, Sun D, Nie Q, Yan J. The survival analysis of rifampicin/multidrug-resistant tuberculosis patients based on the levels of inflammatory biomarkers: a retrospective cohort study. Front Cell Infect Microbiol. 2023;13
Komakech K, Semugenze D, Joloba M, Cobelens F, Ssengooba W. Diagnostic accuracy of point-of-care triage tests for pulmonary tuberculosis using host blood protein biomarkers: a systematic review and meta-analysis. eClinicalmedicine. 2025;84
Chegou NN, Mayito J, Meya DB, Miriam A, Dhikusooka F, Rhein J, Sekaggya-Wiltshire C. Monocyte to lymphocyte ratio is highly specific in diagnosing latent tuberculosis and declines significantly following tuberculosis preventive therapy: a cross-sectional and nested prospective observational study. PLoS One. 2023;18(11)
Ranaivomanana P, Razafimahefa A, Ndiaye M, Razafimahatratra C, Ramamonjisoa H, Herindrainy P, Raherison M, Raherinandrasana AH, Rakotonirina J, Hoffmann J, et al. Assessing the effects of diabetes mellitus on the monocyte-to-lymphocyte ratio and the QuantiFERON-TB gold plus assays for tuberculosis treatment monitoring: a prospective cohort study. Front Immunol. 2025;15
Ye Z, Zhu J, Liu C, Lu Q, Wu S, Zhou C, Liang T, Jiang J, Li H, Chen T, et al. Difference between the blood samples of patients with bone and joint tuberculosis and patients with tuberculosis studied using machine learning. Front Surg. 2023;9
Peng A-Z, Kong X-H, Liu S-T, Zhang H-F, Xie L-L, Ma L-J, Zhang Q, Chen Y. Explainable machine learning for early predicting treatment failure risk among patients with TB-diabetes comorbidity. Sci Rep. 2024;14(1)
Kissling M, Fritschi N, Baumann P, Buettcher M, Bonhoeffer J, Naranbhai V, Ritz N. Monocyte, lymphocyte and neutrophil ratios – easy-to-use biomarkers for the diagnosis of pediatric tuberculosis. The Pediatr Infect Disease J. 2023;42(6):520–27
Hua H-B, Wang H-J: monocyte-to-lymphocyte ratio is significantly associated with positive QuantiFERON-TB gold-in-tube and adult survival: an observational study. Sci Rep. 2022;12(1)